ORFLO

ORFLO is a life sciences instrumentation company focused on cell counting and cell characterization systems used in research and bioprocessing quality control workflows. Its core products include the Moxi Z automated cell counter and the Moxi Go benchtop flow cytometer/cell analyzer, which combine electric impedance methods based on the Coulter Principle with fluorescence detection and a patented disposable microfluidic flow cell format. The company serves cell and gene therapy, bioprocessing, biotechnology, and academic research customers rather than developing therapeutics. ORFLO has sold thousands of instruments globally and positions its systems as compact, lower-maintenance alternatives to traditional cell counters and flow cytometers. The company was acquired by Gemini Bioproducts in 2019 and then acquired by United BioChannels in 2022, and it continues to operate as an active subsidiary.